Detalhe da pesquisa
1.
Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria.
Molecules
; 25(10)2020 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32456032
2.
Multivalent human antibody-centyrin fusion protein to prevent and treat Staphylococcus aureus infections.
Cell Host Microbe
; 31(5): 751-765.e11, 2023 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098341
3.
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
J Med Chem
; 65(6): 4481-4495, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175750
4.
Identification of biologic agents to neutralize the bicomponent leukocidins of Staphylococcus aureus.
Sci Transl Med
; 11(475)2019 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651319
5.
Staphylococcus aureus Leukocidins Target Endothelial DARC to Cause Lethality in Mice.
Cell Host Microbe
; 25(3): 463-470.e9, 2019 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30799265
6.
Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections.
J Med Chem
; 59(14): 6645-57, 2016 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27336583